购物车
- 全部删除
- 您的购物车当前为空
Anti-CD200 Antibody (9J422) 是一种 Mouse 抗体,靶向 CD200。Anti-CD200 Antibody (9J422) 可用于 ELISA,FCM。
Anti-CD200 Antibody (9J422) 是一种 Mouse 抗体,靶向 CD200。Anti-CD200 Antibody (9J422) 可用于 ELISA,FCM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 μL | ¥ 1,679 | 5日内发货 |
产品描述 | Anti-CD200 Antibody (9J422) is a Mouse antibody targeting CD200. Anti-CD200 Antibody (9J422) can be used in ELISA,FCM. |
别名 | OX-2, OX2, MRC, MOX2, MOX1, Cd200 molecule |
Ig Type | Monoclonal Mouse IgG1 |
克隆号 | 9J422 |
交叉反应 | Human |
验证活性 | Flow cytometric analysis of Human CD200 expression on human whole blood lymphocytes. Cells were stained with purified anti-Human CD200, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. |
应用 | ELISA,FCM |
推荐剂量 | ELISA: 1:1000-1:2000; FCM: 1:25-1:100 |
抗体种类 | Monoclonal |
宿主来源 | Mouse |
构建方式 | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD200 (rh CD200; TMPY-01071; NP_005935.4; Met1-Gly232). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
研究背景 | CD200 (OX-2) is a cell surface glycoprotein that imparts immune privileges by suppressing alloimmune and autoimmune responses through its receptor, CD200R, expressed primarily on myeloid cells. Signals delivered through the CD200:CD200R axis have been shown to play an important role in the regulation of anti-tumor immunity, and overexpression of CD200 has been reported in a number of malignancies, including CLL, as well as on cancer stem cells. The role of CD200-CD200R signaling in immune regulation of the central nervous system has become a popular field of research in recent years. Many studies have shown that there is a close correlation between CD200-CD200R, microglia activation, and Parkinson's disease (PD). The ability of CD200 to suppress myeloid cell activation is critical for maintaining normal tissue homeostasis but may also enhance the survival of migratory neoplastic cells. CD200 and CD200R associate via their respective N-terminal Ig-like domains. CD200 has been characterized as an important immunoregulatory molecule, increased expression of which can lead to decreased transplant rejection, autoimmunity, and allergic disease. Elevated CD200 expression has been reported to be associated with poor prognosis in some human malignancies. Besides, CD200 also plays an important role in prevention of graft rejection, autoimmune diseases and spontaneous abortion.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
偶联 | Unconjugated |
其他可选修饰符 | PE |
可提供抗体种类 | 2 |
免疫原 | Recombinant Human CD200 Protein (TMPY-01071) |
抗原种属 | Human |
研究领域 | Neuroinflammation, Cancer Drug Targets |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
运输方式 | Shipping with blue ice. |
评论内容